Literature DB >> 15890065

Cloning and characterization of the human glutathione synthetase 5'-flanking region.

Taunia D Lee1, Heping Yang, Janet Whang, Shelly C Lu.   

Abstract

GSH synthesis occurs through a two-step enzymatic reaction driven by GCL (glutamate-cysteine ligase; made up of catalytic and modifying subunits) and GSS (glutathione synthetase). In humans, oxidative stress regulates GCL expression in an antioxidant response element-dependent manner via Nrf2 [NFE (nuclear factor erythroid)-related factor 2]. In the rat, GSS and GCL are regulated co-ordinately by oxidative stress, and induction of GSS further increases GSH synthetic capacity. Transcriptional regulation of the human GSS has not been examined. To address this, we have cloned and characterized a 2.2 kb 5'-flanking region of the human GSS. The transcriptional start site is located 80 nt upstream of the translation start site. The human GSS promoter efficiently drove luciferase expression in Chang cells. Overexpression of either Nrf1 or Nrf2 induced the GSS promoter activity by 130 and 168% respectively. Two regions homologous to the NFE2 motif are demonstrated to be important for basal expression of human GSS, as mutation of these sites reduced the promoter activity by 66%. Nrf1, Nrf2 and c-Jun binding to these NFE2 sites under basal conditions was demonstrated using chromatin immunoprecipitation assays. In summary, two NFE2 sites in the human GSS promoter play important roles in the basal expression of GSS and, similar to the GCL subunits, the human GSS gene expression is also regulated by Nrf2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890065      PMCID: PMC1198932          DOI: 10.1042/BJ20050439

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes.

Authors:  R Venugopal; A K Jaiswal
Journal:  Oncogene       Date:  1998-12-17       Impact factor: 9.867

2.  Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene.

Authors:  V Mignotte; L Wall; E deBoer; F Grosveld; P H Romeo
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

3.  Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2.

Authors:  A C Wild; H R Moinova; R T Mulcahy
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

4.  Inducers of gamma-glutamylcysteine synthetase and their effects on glutathione synthetase expression.

Authors:  Z A Huang; H Yang; C Chen; Z Zeng; S C Lu
Journal:  Biochim Biophys Acta       Date:  2000-09-07

Review 5.  Glutathione and its role in cellular functions.

Authors:  H Sies
Journal:  Free Radic Biol Med       Date:  1999-11       Impact factor: 7.376

6.  Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein.

Authors:  J Y Chan; M Kwong
Journal:  Biochim Biophys Acta       Date:  2000-12-15

7.  Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene.

Authors:  J Jeyapaul; A K Jaiswal
Journal:  Biochem Pharmacol       Date:  2000-06-01       Impact factor: 5.858

8.  The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts.

Authors:  M Kwong; Y W Kan; J Y Chan
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  The role of p22 NF-E4 in human globin gene switching.

Authors:  Wenlai Zhou; Quan Zhao; Rosemary Sutton; Helen Cumming; Xi Wang; Loretta Cerruti; Mark Hall; Ruiqiong Wu; John M Cunningham; Stephen M Jane
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

10.  Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity.

Authors:  F Y Lee; D W Siemann; R M Sutherland
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  26 in total

1.  Nrf2 target genes are induced under marginal selenium-deficiency.

Authors:  Mike Müller; Antje Banning; Regina Brigelius-Flohé; Anna Kipp
Journal:  Genes Nutr       Date:  2010-01-29       Impact factor: 5.523

2.  Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-14       Impact factor: 4.219

Review 3.  Molecular mechanisms of Nrf2-mediated antioxidant response.

Authors:  Wenge Li; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

4.  Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.

Authors:  Anju Singh; Manish Bodas; Nobunao Wakabayashi; Fred Bunz; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2010-07-13       Impact factor: 8.401

5.  Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.

Authors:  Anju Singh; Hailong Wu; Ping Zhang; Christine Happel; Jinfang Ma; Shyam Biswal
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

Review 6.  Glutathione synthesis.

Authors:  Shelly C Lu
Journal:  Biochim Biophys Acta       Date:  2012-09-17

Review 7.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

8.  Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.

Authors:  Itzy E Morales Pantoja; Che-Lin Hu; Nora I Perrone-Bizzozero; Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2016-09-19       Impact factor: 5.372

9.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.

Authors:  Anju Singh; Swetlana Boldin-Adamsky; Rajesh K Thimmulappa; Srikanta K Rath; Hagit Ashush; Jonathan Coulter; Amanda Blackford; Steven N Goodman; Fred Bunz; Walter H Watson; Edward Gabrielson; Elena Feinstein; Shyam Biswal
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.

Authors:  Heping Yang; Komal Ramani; Meng Xia; Kwang Suk Ko; Tony W H Li; Pilsoo Oh; Jiaping Li; Shelly C Lu
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.